Alkahest Competitors and Similar CompaniesClear all
Alkahest's competitors and similar companies include FORMA Therapeutics, Melinta Therapeutics, GBT (Global Blood Therapeutics) and Travere Therapeutics.
 FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. |  Melinta Therapeutics Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
|  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | ||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2000 | Founding Date 2012 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations San Carlos, US HQ | Locations Watertown, US HQ | Locations Morristown, US HQ New Haven, US | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ Dublin, IE |
Employees | Employees 462% decrease | Employees 77 | Employees 1712% increase | Employees 352106% increase | Employees 46293% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 998.7 m | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $490.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $10.3m (FY, 2025) |
Net income | Net income N/A | Net income ($173m) (FY, 2021) | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income ($25.5m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 37.5m (about 11 years ago) | Latest funding round N/A | Latest funding round $ 123.2m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 41m | Total funding raised $ 142.5m | Total funding raised $ 519.2m | Total funding raised $ 88.7m | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
FORMA Therapeutics
HQ
Watertown, US
Employees
77
FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
View companyMelinta Therapeutics
HQ
Morristown, US
Employees
171↑ 2% increase
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View company